Certified Advisory Corp’s Gilead Sciences GILD Stock Holding History

Certified Advisory Corp’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$850K	Buy	6,732 +441	+7%	+$58.1K	0.07%	181
2026 Q1	$877K	Sell	6,291 -717	-10%	-$100K	0.08%	171
2025 Q4	$860K	Sell	7,008 -3,196	-31%	-$388K	0.08%	168
2025 Q3	$1.13M	Buy	10,204 +2	+0%	+$227	0.11%	150
2025 Q2	$1.13M	Buy	10,202 +35	+0.3%	+$3.73K	0.12%	143
2025 Q1	$1.14M	Sell	10,167 -297	-3%	-$30.6K	0.13%	142
2024 Q4	$967K	Sell	10,464 -13	-0.1%	-$1.17K	0.1%	149
2024 Q3	$878K	Sell	10,477 -222	-2%	-$16.9K	0.1%	155
2024 Q2	$734K	Sell	10,699 -549	-5%	-$36.6K	0.09%	158
2024 Q1	$824K	Sell	11,248 -134	-1%	-$10.3K	0.12%	143
2023 Q4	$922K	Sell	11,382 -230	-2%	-$17.9K	0.14%	132
2023 Q3	$870K	Sell	11,612 -593	-5%	-$45.6K	0.16%	115
2023 Q2	$941K	Sell	12,205 -142	-1%	-$11.3K	0.17%	114
2023 Q1	$1.02M	Buy	12,347 +9	+0.1%	+$745	0.18%	118
2022 Q4	$1.06M	Sell	12,338 -12	-0.1%	-$950	0.21%	112
2022 Q3	$761K	Sell	12,350 -1,807	-13%	-$114K	0.17%	125
2022 Q2	$875K	Buy	14,157 +20	+0.1%	+$1.24K	0.2%	122
2022 Q1	$840K	Buy	14,137 +128	+0.9%	+$8.18K	0.18%	123
2021 Q4	$1.02M	Sell	14,009 -288	-2%	-$19.8K	0.22%	108
2021 Q3	$999K	Buy	14,297 +161	+1%	+$11.3K	0.24%	101
2021 Q2	$974K	Sell	14,136 -173	-1%	-$11.6K	0.24%	100
2021 Q1	$925K	Buy	+14,309	New	+$923K	0.24%	95
2020 Q2	$1.14M	Buy	14,850 +125	+0.8%	+$9.58K	0.38%	62
2020 Q1	$1.1M	Sell	14,725 -622	-4%	-$43K	0.44%	56
2019 Q4	$998K	Sell	15,347 -1,695	-10%	-$110K	0.32%	78
2019 Q3	$1.08M	Sell	17,042 -2,212	-11%	-$145K	0.38%	63
2019 Q2	$1.3M	Sell	19,254 -77	-0.4%	-$5.07K	0.48%	50
2019 Q1	$1.26M	Sell	19,331 -140	-0.7%	-$9.3K	0.53%	44
2018 Q4	$1.22M	Sell	19,471 -1,814	-9%	-$127K	0.63%	35
2018 Q3	$1.64M	Buy	21,285 +20	+0.1%	+$1.51K	0.76%	29
2018 Q2	$1.51M	Sell	21,265 -996	-4%	-$70.3K	0.84%	27
2018 Q1	$1.68M	Buy	22,261 +20,382	+1,085%	+$1.62M	0.99%	24
2017 Q4	$133K	Buy	+1,879	New	+$143K	0.1%	145

Other funds holding GILD

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Certified Advisory Corp's GILD Position: Q2 2026 in Review

Certified Advisory Corp increased its Gilead Sciences (GILD) stake by 7% in Q2 2026, buying an estimated $58.1K and bringing the position to 6,732 shares worth $850K. The position accounts for 0.07% of the portfolio, ranked #181.

Certified Advisory Corp first reported a position in GILD in Q4 2017 and has held it in 33 quarters since. The position peaked at $1.68M in Q1 2018. 747 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Certified Advisory Corp held 6,732 shares of Gilead Sciences worth $850K as of Q2 2026.
Certified Advisory Corp bought 441 Gilead Sciences shares in Q2 2026, an estimated $58.1K.
Gilead Sciences made up 0.07% of Certified Advisory Corp's portfolio in Q2 2026, its #181 holding.
Certified Advisory Corp first reported a position in Gilead Sciences in Q4 2017 and has held it in 33 quarters since.
Certified Advisory Corp's Gilead Sciences position peaked at $1.68M in Q1 2018.
747 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Certified Advisory Corp's 13F filing for Q2 2026, filed 16 Jul 2026.